The frequency of follicle stimulating hormone receptor gene polymorphisms in Iranian infertile men with azoospermia

International Journal of Reproductive BioMedicine

Volumn 13, Issue 11, 2015, Pages 673-678

  Gharesi Fard, Behrouz ^a,b,c   Ghasemi, Zahra ^d   Shakeri, Saeed ^a   Behdin, Shabnam ^e   Aghaei, Fatemeh ^a   Malek Hosseini, Zahra ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Azoospermia; FSH receptor; Male infertility; Polymorphism

Indexed keywords

FOLLITROPIN;

ADULT; ARTICLE; AZOOSPERMIA; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRANIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84975489117     PISSN: 24764108     EISSN: 24763772     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rostami Dovom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Hashemi S, Noroozzadeh M. A population-based study on infertility and its influencing factors in four selected provinces in Iran (2008-2010). Iran J Reprod Med 2014; 12: 561-566.
2. Esteves SC, Miyaoka R, Agarwal A. An update on the clinical assessment of the infertile male. Clinics 2011; 66: 691-700.
3. Cavallini G, Beretta G, Biagiotti G. Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian J Androl 2011; 13: 895-897.
4. Esteves SC, Agarwal A. Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review. Clinics 2013; 68: 141-150.
5. Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997; 15: 205-206.
6. Themmen AP. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005; 130: 263-274.
7. Ahda Y, Gromoll J, Wunsch A, Asatiani K, Zitzmann M, Nieschlag E, et al. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 2005; 26: 494-499.
8. Balkan M, Gedik A, Akkoc H, Ay O, Erdal ME, Isi H, et al. FSHR Single Nucleotide Polymorphism Frequencies in Proven Fathers and Infertile Men in Southeast Turkey. J Biomed Biotechnol 2010; 2010: 640318.
9. Tüttelmann F, Rajpert-De Meyts E, Nieschlag E, Simoni M. Gene polymorphisms and male infertility--a meta-analysis and literature review. Reprod Biomed Online 2007; 15: 643-658.
10. Tüttelmann F, Laan M, Grigorova M, Punab M, Sõber S, Gromoll J. Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male reproductive parameters. J Clin Endocrinol Metab 2012; 97: 3639-3647.
11. Lend AK, Belousova A, Haller-Kikkatalo K, Punab M, Poolamets O, Peters M, et al. Follicle-stimulating hormone receptor gene haplotypes and male infertility in estonian population and meta-analysis. Syst Biol Reprod Med 2010; 56: 84-90.
12. Wu W, Cai H, Sun H, Lu J, Zhao D, Qin Y, et al. Follicle stimulating hormone receptor G-29A, 919A>G, 2039A>G polymorphism and the risk of male infertility: a meta-analysis. Gene 2012; 505: 388-392.
13. Tuerlings JH, Ligtenberg MJ, Kremer JA, Siers M, Meuleman EJ, Braat DD, et al. Screening male intracytoplasmic sperm injectioncandidates for mutations of the follicle stimulatinghormone receptor gene. Hum Reprod 1998; 13: 2098-2101.
14. Pengo M, Ferlin A, Arredi B, Ganz F, Selice R, Garolla A, et al. FSH receptor gene polymorphisms in fertile and infertile Italian men. Reprod Biomed Online 2006; 13: 795-800.
15. Ghirelli-Filho M, Peluso C, Christofolini DM, Gava MM, Glina S, Barbosa CP, et al. Variants in follicle-stimulating hormone receptor gene in infertile Brazilian men and the correlation to FSH serum levels and sperm count. Reprod Sci 2012; 19: 733-739.
16. Li JW, Gu YQ. Predictors for partial suppression of spermatogenesis of hormonal male contraception. Asian J Androl 2008; 10: 723-730.
17. Ishikawa T, Fujisawa M, Tapanainen J. Screening of FSH receptor gene mutation (C566T) in azoospermic men in Japan. Arch Androl 2006; 52: 15-19.
18. Sheikhha MH, Eftekhar M, Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci 2011; 4: 86–90.
19. Bergmann M, Behre HM, Nieschlag E. Serum FSH and testicular morphology in male infertility. Clin Endocrinol 1994; 40: 133-136.
20. Davis D, Liu X, Segaloff DL. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 1995; 9: 159-170.
21. Morón FJ, Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics 2010; 11: 1613-1618.
22. Grover A, Sairam MR, Smith CE, Hermo L. Structural and functional modifications of sertoli cells in the testis of adult follicle-stimulating hormone receptor knockout mice. Biol Reprod 2004; 71: 117-129.
23. Grover A, Smith CE, Gregory M, Cyr DG, Sairam MR, Hermo L. Effects of FSH receptor deletion on epididymal tubules and sperm morphology, numbers, and motility. Mol Reprod Dev 2005; 72: 135-144.
24. Majumdar SS, Sarda K, Bhattacharya I, Plant TM. Insufficient androgen and FSH signalling may be responsible for the azoospermia of the infantile primate testes despite exposure to an adult-like hormonal milieu. Hum Reprod 2012; 27: 2515-2525.
25. Dierich A, Ram Sairam M, Monaco L, Maria Fimia G, Gansmuller A, LeMeur M, et al. Impairingfolliclestimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 1998; 95: 13612-13617.